FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Vaccines and Related Biological Products Advisory Committee

horizontal rule

May 21, 2002 Meeting

Date and Time:

The meeting will be held on May 21, 2002, 8:30 a.m. to 4:30 p.m.

Location:

Hilton Hotel, 8727 Colesville Road, Silver Spring, MD 20910, 301-589-5200

Contact Person:

Jody G. Sachs, D.P.M. or Denise H. Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12391. Please call the Information Line for up-to-date information on this meeting.

Agenda:

In the morning the committee will discuss acute otitis media indication for Prevnar® (Pneumococcal 7-valent Conjugate Vaccine). In the afternoon the FDA will present an update to the committee on the GSK Lyme Disease Vaccine (LYMErixT).

Oral Presentations:

Between approximately 1:15 and 1:45 p.m., and 3:30 to 4:15 p.m. EST oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before May 14, 2002.

 

 
horizontal rule